You just read:

Celsion Corporation and myTomorrows Partner to Introduce ThermoDox® Early Access Program in Europe for Patients with Recurrent Chest Wall Breast Cancer

News provided by

Celsion Corporation

Jan 20, 2015, 08:00 ET